FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to biotechnology. Particularly, the present invention presents a method for providing the higher expression of markers associated with pancreatic endocrine cell line with the use a TGF-beta receptor agonist, such as activin A, activin B, activin C, GDF-8, GDF-11 or GDF-15.
EFFECT: present invention presents methods for stimulating the differentiation of pluripotent stem cells.
7 cl, 4 dwg, 2 ex
Authors
Dates
2014-09-20—Published
2009-10-22—Filed